SPONSOR
European Institute of Oncology
Total Trials
9
Recruiting
9
Phases
N/A
Conditions studied: Invasive Breast CancerHER2-positive Breast CancerTriple Negative Breast CancerLung DiseaseNSCLC (Non-small Cell Lung Cancer)SCLCSmall Bowel NeoplasiaNeuroendocrine (NE) TumorsMastectomy and Breast ReconstructionSexual Wellness
European Institute of Oncology is a clinical research sponsor with 9 registered studies on ClinicalTrials.gov, of which 9 are actively recruiting participants. Research covers conditions including Invasive Breast Cancer, HER2-positive Breast Cancer, Triple Negative Breast Cancer, Lung Disease.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — European Institute of Oncology
How many clinical trials has European Institute of Oncology sponsored?
ClinicalMetric currently tracks 9 clinical trials sponsored by European Institute of Oncology, of which 9 are actively recruiting participants. These trials cover conditions including Invasive Breast Cancer, HER2-positive Breast Cancer, Triple Negative Breast Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does European Institute of Oncology research focus on?
European Institute of Oncology clinical trials span Invasive Breast Cancer, HER2-positive Breast Cancer, Triple Negative Breast Cancer, Lung Disease, NSCLC (Non-small Cell Lung Cancer), and additional conditions. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a European Institute of Oncology clinical trial?
To participate in a European Institute of Oncology trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all European Institute of Oncology trials with current recruitment status updated daily.
Clinical Trials by European Institute of Oncology
NCT06328465
Recruiting
fREEDOM: REsonance for Early Detection Of Breast Cancer Metastases
Invasive Breast Cancer
NCT06727370
Recruiting
Cognitive Screening in Lung Cancer Patients
Lung Disease
NCT06773624
Recruiting
Use of 68Ga-DOTATOC PET/CT-enterography for Detection of the Primary Lesion in Neuroendocrine Tumors of the Small Bowel
Small Bowel Neoplasia
NCT07234461
Recruiting
Sexual Well-being of Women Undergoing Mastectomy and Reconstruction
Mastectomy and Breast Reconstruction
NCT07419893
Recruiting
Germline Genetic Testing of the TP53 Gene
TP53 Gene Mutation
NCT06333587
Recruiting
Minimally Invasive Treatments of the Thyroid
Papillary Thyroid Microcarcinoma
NCT06331013
Recruiting
CyberKnife Ultra-hypofractionated SBRT for Localized PROStatE cancEr
Prostate Cancer
NCT06337760
Recruiting
YOUNg Adults With Gastro-inteSTinal (GI) and nEuroendocrine canceRs.
Neuroendocrine Neoplasm
NCT06790264
Recruiting
Exploring the Tumor Micro-Environment with 68Ga-FAPi-46 PET/CT in Breast Cancer
Breast Cancer Invasive
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology